Fibrocell Science, Inc. Announces Third Quarter 2013 Financial Results
Published: Nov 14, 2013
Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for skin diseases and conditions, particularly those with high unmet medical needs, today announced financial results for the third quarter ended September 30, 2013 and provided an update on recent business developments.
Help employers find you! Check out all the jobs and post your resume.